AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Medtronic: Needham reiterates the 'Hold' Rating
ByAinvest
Friday, Jun 6, 2025 8:00 am ET1min read
Needham reiterates 'Hold' rating on Medtronic(MDT).
[Recent Rating]
| Date | Agency | Change | Rating | Rating （previously） | Target Price | Target Price（previously） |
|---|---|---|---|---|---|---|
| 2025-06-06 | Needham | Reiterates | Hold | Hold | $-- | $-- |
| 2025-05-22 | Needham | Reiterates | Hold | Hold | $-- | $-- |
| 2025-05-22 | RBC Capital | Maintains | Outperform | Outperform | $101 | $105 |
| 2025-05-22 | Mizuho | Maintains | Outperform | Outperform | $98 | $100 |
| 2025-05-22 | Baird | Maintains | Neutral | Neutral | $92 | $94 |
| 2025-05-19 | Needham | Reiterates | Hold | Hold | $-- | $-- |
[Company Profile] Medtronic Plc was founded in 1949.Medtronic plc is the successor registrant to Medtronic, Inc., a Minnesota corporation, was incorporated in Ireland on June 12, 2014 as a private limited company, and was re-registered effective January 26, 2015 as a public limited company. The Company was established for the purpose of facilitating the acquisition of Covidien plc, a public limited company organized under the laws of Ireland (Covidien), which closed on January 26, 2015 (Acquisition Date).Medtronic plc, headquartered in Dublin, Ireland, is among the world's largest medical technology, services, and solutions companies - alleviating pain, restoring health, and extending life for millions of people around the world. And today serves hospitals, physicians, clinicians, and patients in more than 150 countries worldwide. The company primary customers include hospitals, clinics, third-party healthcare providers, distributors, and other institutions, including governmental healthcare programs and group purchasing organizations (GPOs).
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet